ArticleCureus2026
Unique Presentation of an Arteriovenous Malformation (AVM) in the Hand: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arteriovenous malformations (AVMs) of the hand are challenging high-flow vascular anomalies. While often stable for years, they can progress into higher Schobinger stages, where ulceration, hemorrhage, distal ischemia, and, in advanced cases, congestive heart failure are characteristic. Incomplete prior interventions often exacerbate these outcomes. A 39-year-old male with a 12-year history of a stable hand AVM presented with sudden expansion, spontaneous hemorrhage, and gangrenous skin changes. Clinical evaluation revealed hematoma and vascular steal syndrome. Imaging (MRI and DSA) confirmed a large (8x7x6 cm) extratruncular high-flow AVM involving the volar and ulnar aspects of the hand. The patient was managed with intravenous antibiotics and a staged multidisciplinary approach including selective arterial embolization with mechanical coils and liquid embolic agents, followed by radical surgical excision 48 hours later. Advanced hand AVMs require a "total obliteration" strategy. This case highlights the success of combining endovascular modulation with surgical resection to achieve limb salvage in a stage III lesion. Lifelong surveillance is mandatory due to the high risk of recurrence from dormant microscopic vascular nests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.